tiprankstipranks
Advertisement
Advertisement
Metagenomi, Inc. Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsMetagenomi, Inc. Reports Q3 2025 Financial Results
6M ago
Metagenomi price target lowered to $7 from $11 at Chardan
Premium
The Fly
Metagenomi price target lowered to $7 from $11 at Chardan
6M ago
Metagenomi Announces Positive Preclinical Data for MGX-001
Premium
Company Announcements
Metagenomi Announces Positive Preclinical Data for MGX-001
6M ago
MGX Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsMGX Upcoming Earnings Report: What to Expect?
6M ago
Video: This stock is dragging down the in vivo gene editing therapy space
Premium
The Fly
Video: This stock is dragging down the in vivo gene editing therapy space
6M ago
Intellia Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
Premium
The Fly
Intellia Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
6M ago
Metagenomi price target lowered to $11 from $12 at Chardan
PremiumThe FlyMetagenomi price target lowered to $11 from $12 at Chardan
9M ago
Premium
Company Announcements
Metagenomi, Inc. Reports Q2 2025 Financial Results
9M ago
Metagenomi reports Q2 EPS (54c), consensus (61c)
Premium
The Fly
Metagenomi reports Q2 EPS (54c), consensus (61c)
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100